Nubeqa (darolutamide tablets - Bayer) — Cigna
Prostate Cancer – Non-Metastatic, Castration-Resistant
Initial criteria
- Patient age ≥ 18 years
- Medication is used concurrently with a gonadotropin-releasing hormone (GnRH) analog OR patient has had a bilateral orchiectomy
Approval duration
1 year